肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

2021 共识指南：血液科、肿瘤科以及重症监护室侵袭性念珠菌病的诊断和管理

2021-11-25 澳大利亚皇家医师学院 Intern Med J

侵袭性念珠菌病真菌组传

血液系统恶性肿瘤、造血干细胞移植以及重症监护室内患者均有侵袭性念珠菌病高风险。本文主要针对血液科、肿瘤科以及重症监护室侵袭性念珠菌病的诊断和管理提供最新循证指导建议，并讨论了最佳药物和非药物治疗。

中文标题：

2021 共识指南：血液科、肿瘤科以及重症监护室侵袭性念珠菌病的诊断和管理

英文标题：

Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021

发布机构：

澳大利亚皇家医师学院

发布日期：

2021-11-25

简要介绍：

血液系统恶性肿瘤、造血干细胞移植以及重症监护室内患者均有侵袭性念珠菌病高风险。本文主要针对血液科、肿瘤科以及重症监护室侵袭性念珠菌病的诊断和管理提供最新循证指导建议，并讨论了最佳药物和非药物治疗。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 共识指南：血液科、肿瘤科以及重症监护室侵袭性念珠菌病的诊断和管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=82a581c002301ebc, title=2021 共识指南：血液科、肿瘤科以及重症监护室侵袭性念珠菌病的诊断和管理, enTitle=Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021, guiderFrom=Intern Med J, authorId=0, author=, summary=血液系统恶性肿瘤、造血干细胞移植以及重症监护室内患者均有侵袭性念珠菌病高风险。本文主要针对血液科、肿瘤科以及重症监护室侵袭性念珠菌病的诊断和管理提供最新循证指导建议，并讨论了最佳药物和非药物治疗。, cover=https://img.medsci.cn/20211224/1640355929271_1608702.jpg, journalId=0, articlesId=null, associationId=429, associationName=澳大利亚皇家医师学院, associationIntro=The RACP has various training pathways, linked to comprehensive training curricula, complemented by an extensive and wide-ranging program of on-the-job training, working with and learning from experienced clinicians. Becoming a Physician involves a significant amount of training, time and commitment and we have provided below some information on areas of interest and training options., copyright=0, guiderPublishedTime=Thu Nov 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">血液系统恶性肿瘤、造血干细胞移植以及重症监护室内患者均有侵袭性念珠菌病高风险。本文主要针对血液科、肿瘤科以及重症监护室侵袭性念珠菌病的诊断和管理提供最新循证指导建议，并讨论了最佳药物和非药物治疗。</span></p>, tagList=[TagDto(tagId=57077, tagName=侵袭性念珠菌病), TagDto(tagId=120357, tagName=真菌组传)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=57077, guiderKeyword=侵袭性念珠菌病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=9, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2095, appHits=112, showAppHits=0, pcHits=472, showPcHits=1983, likes=0, shares=13, comments=6, approvalStatus=1, publishedTime=Fri Dec 24 22:21:24 CST 2021, publishedTimeString=2021-11-25, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Fri Dec 24 22:30:52 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 05:55:27 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 共识指南：血液科、肿瘤科以及重症监护室侵袭性念珠菌病的诊断和管理.pdf)])
2021 共识指南：血液科、肿瘤科以及重症监护室侵袭性念珠菌病的诊断和管理.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1215314, encodeId=2ece12153149d, content=能不能买积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/e038f3710b6a4a07a25c3a1404ab9cf4/96bfbef4ac9b49838a6a99c239e3b130.jpg, createdBy=68de2537060, createdName=12513455m57暂无昵称, createdTime=Thu Apr 28 14:40:59 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215311, encodeId=0aa3121531179, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/e038f3710b6a4a07a25c3a1404ab9cf4/96bfbef4ac9b49838a6a99c239e3b130.jpg, createdBy=68de2537060, createdName=12513455m57暂无昵称, createdTime=Thu Apr 28 14:38:13 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194950, encodeId=2f9d1194950a4, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Feb 19 00:31:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186729, encodeId=a3d11186e29d9, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3818101931, createdName=wjl066452, createdTime=Fri Jan 21 10:08:37 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-04-28 12513455m57暂无昵称

    能不能买积分啊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1215314, encodeId=2ece12153149d, content=能不能买积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/e038f3710b6a4a07a25c3a1404ab9cf4/96bfbef4ac9b49838a6a99c239e3b130.jpg, createdBy=68de2537060, createdName=12513455m57暂无昵称, createdTime=Thu Apr 28 14:40:59 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215311, encodeId=0aa3121531179, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/e038f3710b6a4a07a25c3a1404ab9cf4/96bfbef4ac9b49838a6a99c239e3b130.jpg, createdBy=68de2537060, createdName=12513455m57暂无昵称, createdTime=Thu Apr 28 14:38:13 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194950, encodeId=2f9d1194950a4, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Feb 19 00:31:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186729, encodeId=a3d11186e29d9, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3818101931, createdName=wjl066452, createdTime=Fri Jan 21 10:08:37 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-04-28 12513455m57暂无昵称

    ***

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1215314, encodeId=2ece12153149d, content=能不能买积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/e038f3710b6a4a07a25c3a1404ab9cf4/96bfbef4ac9b49838a6a99c239e3b130.jpg, createdBy=68de2537060, createdName=12513455m57暂无昵称, createdTime=Thu Apr 28 14:40:59 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215311, encodeId=0aa3121531179, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/e038f3710b6a4a07a25c3a1404ab9cf4/96bfbef4ac9b49838a6a99c239e3b130.jpg, createdBy=68de2537060, createdName=12513455m57暂无昵称, createdTime=Thu Apr 28 14:38:13 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194950, encodeId=2f9d1194950a4, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Feb 19 00:31:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186729, encodeId=a3d11186e29d9, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3818101931, createdName=wjl066452, createdTime=Fri Jan 21 10:08:37 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-02-19 suibian2007bbb

    谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1215314, encodeId=2ece12153149d, content=能不能买积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/e038f3710b6a4a07a25c3a1404ab9cf4/96bfbef4ac9b49838a6a99c239e3b130.jpg, createdBy=68de2537060, createdName=12513455m57暂无昵称, createdTime=Thu Apr 28 14:40:59 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215311, encodeId=0aa3121531179, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/e038f3710b6a4a07a25c3a1404ab9cf4/96bfbef4ac9b49838a6a99c239e3b130.jpg, createdBy=68de2537060, createdName=12513455m57暂无昵称, createdTime=Thu Apr 28 14:38:13 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194950, encodeId=2f9d1194950a4, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Feb 19 00:31:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186729, encodeId=a3d11186e29d9, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3818101931, createdName=wjl066452, createdTime=Fri Jan 21 10:08:37 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-01-21 wjl066452

    非常好

    0

拓展阅读

2017 ESICM/ESCMID指南：重症患者侵袭性念珠菌病实用管理工作组

暂未更新 · 2018-11-06

2023 ASTCT指南：造血细胞移植受者侵袭性念珠菌病的管理

美国移植与细胞治疗学会(ASTCT,American Society for Transplantation and Cellular Therapy) · 2023-04-02

2024 GMMMG 非血液肿瘤成人患者的侵袭性念珠菌病 (173)

（GMMMG ，greater manchester medicines management group） 大曼彻斯特药品管理组 · 2024-01-31